Oncolytics Reports Overall, KRAS-Mutated Patient Data from US Randomized Phase 2 Pancreatic Cancer Study
September 16, 2014 at 17:08 PM EDT
Oncolytics Biotech^® Inc. ("Oncolytics") (NASDAQ: ONCY) today announced overall and KRAS-mutated patient data from a two-arm ...
